Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (5)
Type
Type
Guidance (119)
NICE advice (17)
Quality standard (8)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (3)
Antimicrobial resistance guidance (2)
Clinical guidelines (10)
HealthTech guidance (37)
Highly specialised technologies guidance (5)
NICE guidelines (17)
Public health guidelines (5)
Social care guidelines (2)
Technology appraisal guidance (58)
Advice programme
Advice programme
Evidence summaries (2)
Medtech innovation briefings (15)
Apply filters
Showing 51 to 100 of 144
Sort by
Date
Title
Apply sorting
Last updated date between: 1/2/2022 and 31/8/2022
Remove Last updated date between: 1/2/2022 and 31/8/2022 filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Fremanezumab for preventing migraine
TA764
2 February 2022
2 February 2022
Gout: diagnosis and management
NG219
9 June 2022
9 June 2022
Granulox for managing chronic non-healing wounds
MIB296
10 May 2022
10 May 2022
Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs
TA815
10 August 2022
10 August 2022
Ibrutinib for treating Waldenstrom's macroglobulinaemia
TA795
8 June 2022
8 June 2022
icobrain ms for active relapsing–remitting multiple sclerosis
MIB291
29 March 2022
29 March 2022
Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides
TA805
13 July 2022
13 July 2022
iFuse for treating chronic sacroiliac joint pain
HTG488
2 October 2018
30 August 2022
Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney disease
TA809
20 July 2022
20 July 2022
Integrated health and social care for people experiencing homelessness
NG214
16 March 2022
16 March 2022
Intramedullary distraction for lower limb lengthening
HTG613
2 March 2022
2 March 2022
Intramedullary distraction for upper limb lengthening
HTG621
20 April 2022
20 April 2022
Joint replacement (primary): hip, knee and shoulder
QS206
29 March 2022
29 March 2022
Lenalidomide for relapsed or refractory mantle cell lymphoma (terminated appraisal)
TA774
9 March 2022
9 March 2022
Liposuction for chronic lipoedema
HTG618
29 March 2022
29 March 2022
Liposuction for chronic lymphoedema
HTG622
27 April 2022
27 April 2022
Lumella point-of-care test for assessing pre-eclampsia risk
MIB287
1 March 2022
1 March 2022
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults
NG215
20 April 2022
20 April 2022
Melanoma: assessment and management
NG14
29 July 2015
27 July 2022
Mental wellbeing at work
NG212
2 March 2022
2 March 2022
Microwave ablation for primary or metastatic cancer in the lung
HTG609
2 February 2022
2 February 2022
MiraQ for assessing graft flow during coronary artery bypass graft surgery
HTG275
16 November 2011
5 July 2022
Multiple sclerosis in adults: management
NG220
22 June 2022
22 June 2022
Neonatal parenteral nutrition
QS205
22 March 2022
22 March 2022
Nerve graft for corneal denervation
HTG629
29 June 2022
29 June 2022
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer
TA784
20 April 2022
20 April 2022
Nivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrence
TA817
10 August 2022
10 August 2022
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)
TA785
20 April 2022
20 April 2022
Nivolumab with ipilimumab for untreated advanced renal cell carcinoma
TA780
24 March 2022
24 March 2022
Nivolumab with ipilimumab for untreated unresectable malignant pleural mesothelioma
TA818
17 August 2022
17 August 2022
Odevixibat for treating progressive familial intrahepatic cholestasis
HST17
22 February 2022
22 February 2022
Otitis media (acute): antimicrobial prescribing
NG91
28 March 2018
11 March 2022
Palforzia for treating peanut allergy in children and young people
TA769
2 February 2022
2 February 2022
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria
TA778
9 March 2022
9 March 2022
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanoma
TA766
2 February 2022
2 February 2022
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapies
TA772
23 February 2022
23 February 2022
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancer
TA801
29 June 2022
29 June 2022
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer
TA770
9 February 2022
9 February 2022
Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitis
HTG617
9 March 2022
9 March 2022
Peristeen Plus transanal irrigation system for managing bowel dysfunction
HTG462
23 February 2018
6 June 2022
PeritX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites
HTG282
21 March 2012
19 July 2022
Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndrome
HTG623
18 May 2022
18 May 2022
Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoea
TA776
9 March 2022
9 March 2022
PLGF-based testing to help diagnose suspected preterm pre-eclampsia
HTG630
27 July 2022
27 July 2022
Ponesimod for treating relapsing–remitting multiple sclerosis
TA767
2 February 2022
2 February 2022
Pralsetinib for treating RET fusion-positive advanced non-small-cell lung cancer
TA812
3 August 2022
3 August 2022
PredictSURE IBD and IBDX to guide treatment of Crohn's disease
HTG610
23 February 2022
23 February 2022
Preterm labour and birth
NG25
20 November 2015
10 June 2022
ProciseDx point-of-care platform for inflammatory bowel disease
MIB302
12 July 2022
12 July 2022
Prontosan for treating acute and chronic wounds
HTG616
8 March 2022
8 March 2022
Previous page
1
Current page
2
3
Page
2
of
3
Next page
Results per page
10
25
50
All
Back to top